Table 1. Baseline characteristics.
White Light | 5-ALA | Total | p-value | |||||
---|---|---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | |||
Age | > 65 years | 52 | 44% | 24 | 43% | 76 | 43% | 0.917 |
≤ 65 years | 67 | 56% | 32 | 57% | 99 | 57% | ||
Sex | Female | 53 | 45% | 27 | 48% | 80 | 46% | 0.649 |
Male | 66 | 55% | 29 | 52% | 95 | 54% | ||
KPS | < 80 | 37 | 31% | 15 | 27% | 52 | 30% | 0.561 |
≥ 80 | 82 | 69% | 41 | 73% | 123 | 70% | ||
Histology | NSCLC | 40 | 33% | 23 | 41% | 63 | 37% | 0.491 |
GIT | 18 | 15% | 7 | 13% | 25 | 14% | ||
Breast | 19 | 16% | 7 | 13% | 26 | 15% | ||
Melanoma | 14 | 12% | 11 | 20% | 25 | 14% | ||
SCLC | 16 | 13% | 4 | 6.5% | 20 | 11% | ||
Other | 12 | 11% | 4 | 6.5% | 16 | 9% | ||
Disease status | Disseminated | 65 | 55% | 23 | 41% | 88 | 50% | 0.094 |
Not dissem. | 54 | 45% | 33 | 59% | 87 | 50% | ||
Eloquence | Non-eloquent | 89 | 75% | 40 | 71% | 129 | 74% | 0.637 |
Eloquent | 30 | 25% | 16 | 29% | 46 | 26% | ||
Diameter | > 30 mm | 61 | 51% | 25 | 45% | 86 | 49% | 0.476 |
≤ 30 mm | 58 | 49% | 30 | 55% | 88 | 51% | ||
Brain lesions | Multiple | 63 | 53% | 26 | 46% | 89 | 51% | 0.421 |
Single | 56 | 47% | 30 | 54% | 86 | 49% | ||
Location | Supratentorial | 66 | 56% | 42 | 75% | 108 | 62% | 0.013 |
Infratentorial | 53 | 45% | 14 | 25% | 67 | 38% | ||
Total | 119 | 56 | 175 |